Applications of snake venom components to modulate integrin activities in cell-matrix interactions

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 9, 2013, Pages 1974-1986

  Marcinkiewicz, Cezary ^a  

^a Temple University   (United States)

Author keywords

Angiogenesis; C lectintype proteins; Cell adhesion; Disintegrins; Integrins

Indexed keywords

BINDING PROTEIN; DISINTEGRIN; INTEGRIN; LECTIN; SNAKE VENOM;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; LEUKOCYTE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE;

ANGIOGENESIS; C-LECTIN TYPE PROTEINS; CELL ADHESION; DISINTEGRINS; INTEGRINS;

AMINO ACID SEQUENCE; ANIMALS; DISINTEGRINS; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; SNAKE VENOMS;

EID: 84885126309     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.06.009     Document Type: Review

References (128)

1. Arlinghaus FT, Momic T, Ammar NA, Shai E, Spectre G, Varon D, et al. Identification of α2β 1integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae. Toxicon 2013; 64:96-105.
2. Arlinghaus FT, Eble JA The collagen-binding integrin α2β1 is a novel interaction partner of the Trimeresurus flavoviridis venom protein flavocetin-A. Journal of Biological Chemistry 2013; 288:947-55.
3. Basani RB, Zhu H, Thornton M.A., Soto CS, Degrado WF, Kowalska MA, et al Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller. Blood 2009; 113:902-10.
4. Bazaa A, Marrakchi N, El Ayeb M, Sanz L, Calvete JJ Snake venomics: comparative analysis of the venom proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina. Proteomics 2005; 5:4223-35. (Pubitemid 41626090)
5. Bazaa A, Luis J, Srairi-Abid N, Kallech-Ziri O, Kessentini-Zouari R, Defilles C., et al MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediter-ranea venom, inhibits tumor cells adhesion and migration. Matrix Biology 2009; 28:188-93.
6. Bazan-Socha S., Kisiel DG, Young B, Theakston RDG, Calvete JJ, Sheppard D, et al Structural requirements of MLD-containing disintegrins for functional interaction with α4β1 and α9β1 integrins. Biochemistry 2004; 43:1639-47. (Pubitemid 38200570)
7. Bazan-Socha S., Bukiej A, Pulka G, Marcinkiewicz C, Musial J. Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma. Clinical and Experimental Allergy 2006; 36:1184-91. (Pubitemid 44342934)
8. Bazan-Socha S., Zuk J, Plutecka H., Marcinkiewicz C, Zareba L, Musial J. Collagen receptors α(1)β(1) and α(2)β(1) integrins are involved in transmigration of peripheral blood eosinophils, but not mononuclear cells through human microvascular endothelial cells monolayer. Journal of Physiology and Pharmacology 2012; 63:373-9.
9. Belisario MA, Tafuri S, Di Domenico C, Della Morte R, Squillacioti C, Lucisano A., et al Immobilised echistatin promotes platelet adhesion and protein tyrosine phosphorylation. Biochimica et Biophysica Acta 2000; 1497:227-36. (Pubitemid 30618834)
10. Belisario MA, Tafuri S, Pontarelli G., Staiano N, Gionti E. Modulation of chondrocyte adhesion to collagen by echistatin. European Journal of Cell Biology 2005; 8410:833-42. (Pubitemid 41440015)
11. Bracht T, Figueiredo de Rezende F, Stetefeld J, Sorokin LM, Eble JA. Monoclonal antibodies reveal the alteration of the rhodocetin structure upon α2β1 integrin binding. Biochemical Journal 2011; 440:1-11.
12. Brown MC, Staniszewska I, Del Valle L, Tuszynski GP, Marcinkiewicz C. Angio-static activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth. International Journal of Cancer 2008a; 123:2195-203.
13. Brown MC, Staniszewska I, Lazarovici P., Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro-Oncology 2008b; 10:968-80.
14. Brown MC, Eble JA, Calvete J.J., Marcinkiewicz C. Structural requirements of KTS-disintegrins for inhibition of α1β1 integrin. Biochemical Journal 2009; 417:95-101.
15. Calvete JJ, Fox JW, Agelan A, Niewiarowski S., Marcinkiewicz C. The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on alphaII(b)beta3, alpha(v)beta3, and alpha5beta1 integrins. Biochemistry 2002; 41:2014-21. (Pubitemid 34133978)
16. Calvete JJ, Escolano J, Sanz L. Snake venomics of Bitis species reveals large intragenus venom toxin composition variation: application to taxonomy of congeneric taxa. Journal of Proteome Research 2007; 6:326-36.
17. Calvete JJ. The continuing saga of snake venom disintegrins. Toxicon 2013; 62:40-9.
18. Chang HH, Lin CH, Lo SJ Recombinant rhodostomin substrates induce transformation and active calcium oscillation in human platelets. Experimental Cell Research 1999; 250:387-400. (Pubitemid 29367450)
19. Cheresh DA, Stupack DG Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 2008; 27:6285-98.
20. Clark EA, Trikha M, Markland F.S., Brugge JS Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation. Journal of Biological Chemistry 1994; 269:21940-3. (Pubitemid 24282110)
21. Clemetson KJ. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors. Toxicon 2010; 56:1236-46.
22. Clissa PB, Lopes-Ferreira M, Della-Casa MS, Farsky SH, Moura-da-Silva AM. Importance ofjararhagin disintegrin-like and cysteine-rich domains inthe early events of local inflammatory response. Toxicon 2006; 47:591-6.
23. Coelho AL, de Freitas MS, Oliveira-Carvalho AL, Moura-Neto V, Zingali R.B., Barja-Fidalgo C. Effects of jarastatin, a novel snake venom disintegrin, on neutrophil migration and actin cytoskeleton dynamics. Experimental Cell Research 1999; 251:379-87. (Pubitemid 29431875)
24. Coelho AL, de Freitas MS, Mariano-Oliveira A, Oliveira-Carvalho AL, Zingali R.B., Barja-Fidalgo C. Interaction of disintegrins with human neutrophils induces cytoskeleton reorganization, focal adhesion kinase activation, and extracellular-regulated kinase-2 nuclear translocation, interfering with the chemotactic function. FASEB Journal 2001; 15:1643-5.
25. Coelho AL, De Freitas MS, Mariano-Oliveira A, Rapozo DC, Pinto L.F., Niewiarowski S., et al RGD and MLD-disintegrins, jarastatin and EC3, activate integrin-mediated signaling modulating the human neutrophils chemotaxis, apoptosis and IL-8 gene expression. Experimental Cell Research 2004; 292:371-84. (Pubitemid 38018852)
26. Daidone I, Aschi M, Patamia M., Bozzi A, Petruzzelli R. Structural and dynamical properties of KTS-disintegrins: a comparison between obtustatin and lebestatin. Biopolymers 2012; 99:47-54.
27. Danen EH, Marcinkiewicz C, Cornelissen I.M., van Kraats AA, Pachter JA, Ruiter DJ, et al The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells. Experimental Cell Research 1998; 238:188-96. (Pubitemid 28366141)
28. Davenpeck KL, Marcinkiewicz C, Wang D, Niculescu R, Shi Y, Martin JL, et al. Regional differences in integrin expression: role of alpha(5)beta(1) in regulating smooth muscle cell functions. Circulation Research 2001; 88:352-8. (Pubitemid 32173761)
29. Duan X, Jia SF, Zhou Z, Langley R.R., Bolontrade MF, Kleinerman ES Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells. Clinical and Experimental Metastasis 2004; 21:747-53.
30. Eble JA, Niland S, Bracht T., Mormann M, Peter-Katalinic J, Pohlentz G, et al The alpha2beta1 integrin-specific antagonist rhodocetin is a cruciform, heterote-trameric molecule. FASEB Journal 2009; 23:2917-27.
31. Egbertson MS, Chang CT, Duggan M.E., Gould RJ, Halczenko W, Hartman GD, et al Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. Journal of Medicinal Chemistry 1994; 37:2537-51. (Pubitemid 24276781)
32. Fiorilli P, Partridge D, Staniszewska I., Wang JY, Grabacka M, So K, et al Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation. Laboratory Investigation 2008; 88:1143-56.
33. Fox JW, Serrano SMT. Timeline of key events in snake venom metalloproteinase research. Journal of Proteomics 2009; 72:200-9.
34. Golubkov V, Hawes D, Markland FS Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom. Angiogenesis 2003; 6:213-24. (Pubitemid 38506666)
35. Gupta SK, Oommen S, Aubry M.C., Williams BP, Vlahakis NE Integrin α9β1promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition. Oncogene 2013; 32:141-50.
36. Hailey S, Adams E, Penn R., Wong A, McLane MA Effect of the disintegrin eristostatin on melanoma-natural killer cell interactions. Toxicon 2013; 61:83-93.
37. Hantgan RR, Stahle MC, Connor JH, Lyles DS, Horita DA, Rocco M, et al. The disintegrin echistatin stabilizes integrin alphaIIbbeta3's open conformation and promotes its oligomerization. Journal of Molecular Biology 2004; 342:1625-36. (Pubitemid 39208683)
38. Harburger DS, Calderwood DA Integrin signaling at a glance. Journal of Cell Science 2009; 122:159-63.
39. Harper MM, Ye EA, Blong C.C., Jacobson ML, Sakaguchi DS Integrins contribute to initial morphological development and process outgrowth in rat adult hip-pocampal progenitor cells. Journal of Molecular Neuroscience 2010; 40:269-83.
40. Hong SY, Lee H, You W.K., Chung KH, Kim DS, Song K. The snake venom disintegrin salmosin induces apoptosis by disassembly of focal adhesions in bovine capillary endothelial cells. Biochemical and Biophysical Research Communications 2003; 302:502-8. (Pubitemid 36279558)
41. Hook KM, Bennett JS Glycoprotein IIb/IIIa antagonists. Handbook of Experimental Pharmacology 2012; 210:199-223.
42. Horii K, Okuda D, Morita T, Mizuno H. Structural characterization of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. Biochemistry 2003; 42:12497-502. (Pubitemid 37337539)
43. Horii K, Okuda D, Morita T., Mizuno H. Crystal structure of EMS16 in complex with the integrin alpha2-I domain. Journal of Molecular Biology 2004; 341: 519-27. (Pubitemid 38992304)
44. Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. Journal of Biological Chemistry 1987; 262:16157-63. (Pubitemid 17165208)
45. Huang TF, Yeh CH, Wu WB Viper venom components affecting angiogenesis. Haemostasis 2001; 31:192-206. (Pubitemid 34702052)
46. Humphries JD, Byron A, Humphries MJ Integrin ligands at a glance. Journal of Cell Science 2006; 119:3901-3. (Pubitemid 44650863)
47. Huang TF, Chang CH, Ho P.L., Chung CH FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2. Experimental Hematology 2008; 36:1704-13.
48. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-87. (Pubitemid 35283958)
49. Jakubowski P, Calvete JJ, Eble J.A., Lazarovici P., Marcinkiewicz C. Identification of inhibitors of α2β1 integrin, members of C-type lectin proteins, in Echis sochureki venom. Toxicology and Applied Pharmacology 2013; 269:34-42.
50. Jang Y-J, Jeon O.K., Kim DS Saxatilin, a snake venom disintegrin, regulates platelet activation associated with human vascular endothelial cell migration and invasion. Journal of Vascular Research 2007; 44:129-37.
51. Juarez P, Comas I, González-Candelas F, Calvete JJ. Evolution of snake venom disintegrins by positive Darwinian selection. Molecular Biology and Evolution 2008; 25:2391-407.
52. Juliano D, Wang Y, Marcinkiewicz C., Rosenthal LA, Stewart GJ, Niewiarowski S. Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. Experimental Cell Research 1996; 225:132-42.
53. Kang IC, Kim DS, Jang Y, Chung KH Suppressive mechanism ofsalmosin, a novel dis-integrin in B16 melanoma cell metastasis. Biochemical and Biophysical Research Communications 2000; 275:169-73. (Pubitemid 30663647)
54. Karna E, Szoka L, Palka J. Thrombin-dependent modulation of β1-integrin-mediated signaling up-regulates prolidase and HIF-1αthrough p-FAK in colorectal cancer cells. Molecular and Cellular Biochemistry 2012; 361:235-41.
55. Kauskot A, Cominetti MR, Ramos O.H., Bechyne I., Renard JM, Hoylaerts MF, et al Hemostatic effects of recombinant DisBa-01, a disintegrin from Bothrops alter-natus. Frontiers in Biosciences 2008; 13:6604-16.
56. Kessentini-Zouari R., Jebali J, Taboubi S., Srairi-Abid N, Morjen M, Kallech-Ziri O, et al CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venom-derived phospholi-pasesA2, inhibit angiogenesis both in vitro and in vivo. Laboratory Investigation 2010; 90:510-9.
57. Kisiel DG, Calvete JJ, Katzhendler J, Fertala A, Lazarovici P, Marcinkiewicz C. Structural determinants of the selectivity of KTS-disintegrins forthe α1β1 integrin. FEBS Letters 2004; 577:478-82. (Pubitemid 39535335)
58. Limam I, Bazaa A, Srairi-Abid N, Taboubi S., Jebali J, Zouari-Kessentini R, et al Leberagin-C, a disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterraneavenom, inhibits alphavbeta3integrin-mediated cell adhesion. Matrix Biology 2010; 29:1217-26.
59. Lin E, Wang Q, Swenson S., Jadvar H, Groshen S, Ye W., et al The disintegrin contortro-statin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo. Prostate 2010; 70:1359-70.
60. Long RK, Nishida S, Kubota T., Wang Y, Sakata T, Elalieh H.Z., et al Seletal unloading-induced insulin-like growth factor 1 (IGF-1)nonresponsiveness is not shared by platelet-derived growth factor: the selective role of integrins in IGF-1 signaling. Journal of Bone and Mineral Research 2011; 26:2948-58.
61. Lucena S, Sanchez EE, Perez JC Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the Mohave rattlesnake. Toxicon 2011; 57: 794-802.
62. Lucena SE, Jia Y, Soto J.G., Parral J., Cantu E, Brannon J, et al Anti-invasive and anti-adhesive activities of a recombinant disintegrin, r-viridistatin 2, derived from the Prairie rattlesnake (Crotalus viridis viridis). Toxicon 2012; 60:31-9.
63. Marcinkiewicz C, Rosenthal LA, Mosser D.M., Kunicki TJ, Niewiarowski S. Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochemical Journal 1996; 317:817-25.
64. Marcinkiewicz C, Calvete JJ, Vijay-Kumar S, Marcinkiewicz M.M., Raida M., Schick P, et al Structural and functional characterization of EMF10, a heterodimeric disintegrin from Eristocophis macmahoni venom that selectively inhibits alpha 5 beta 1 integrin. Biochemistry 1999a; 38:13302-9.
65. Marcinkiewicz C, Calvete JJ, Marcinkiewicz M, Raida M., Vijay-Kumar S, Huang Z, et al. EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits a4 nad a5 integrins in an RGD-independent manner. Journal of Biological Chemistry 1999b; 274:12468-73.
66. Marcinkiewicz C, Taooka Y, Yokosaki Y., Calvete JJ, Marcinkiewicz MM, Lobb RR, et al Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha9beta1 with VCAM-1, tenascin-C, and osteopontin. Journal of Biological Chemistry 2000a; 275:31930-7.
67. Marcinkiewicz C, Lobb RR, Marcinkiewicz M.M., Daniel JL, Smith JB, Dangelmaier C, et al. Isolation and characterization of EMS16, a C-type lectin protein from Echis multisquamatus venom, a potent and selective inhibitor of the α2β1 integrin. Biochemistry 2000b; 39:9859-67. (Pubitemid 30626834)
68. Marcinkiewicz C, Wainreb PH, Calvete J.J., Kisiel DG, Mousa SA, Tuszynski GP, et al Obtustatin, a potent inhibitor of α1β1 integrin in vitro and angiogenesis in vivo. Cancer Research 2003; 63:2020-3. (Pubitemid 36538600)
69. Marcinkiewicz C. Functional characteristic of snake venom disintegrins: potential therapeutic implication. Current Pharmaceutical Design 2005; 11:815-27. (Pubitemid 40331033)
70. Mariano-Oliveir A., Coelho AL, Terruggi C.H., Selistre-de-Araujo HS, Barja-Fidalgo C, de Freitas MS. Alternagin-C, a non RGD-disintegrin, induces neutrophil migration via integrin signaling. European Journal of Biochemistry 2003; 270:4799-808. (Pubitemid 38021563)
71. Markland FS, Shieh K, Zhou Q., Golubkov V, Sherwin RP, Richters V, et al A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 2001; 31:183-91. (Pubitemid 34702051)
72. McLane MA, Joerger T, Mahmoud A. Disintegrins in health and disease. Frontiers in Bioscience 2008; 13:6617-37.
73. Minamiguchi K, Kumagai H, Masuda T., Kawada M, Ishizuka M, Takeuchi T. Thio-lutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillinin HUVECs and suppresses tumor cell-induced angiogenesis. International Journal of Cancer 2001; 93:307-16. (Pubitemid 32592047)
74. Momic T, Cohen G, Reich R., Arlinghaus FT, Eble JA, Marcinkiewicz C, et al Vixa-patin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound. Toxins (Basel) 2012; 4: 862-77.
75. Montenegro CF, Salla-Pontes CL, Ribeiro J.U., Machado AZ, Ramos RF, Figueiredo CC, et al Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells. Biochimie 2012; 94:1812-20.
76. Morita T. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet modulating activities. Toxicon 2005; 45:1099-114. (Pubitemid 40732584)
77. Morris VL, Schmidt EE, Koop S, MacDonald I.C., Grattan M., Khokha R, et al Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Experimental Cell Research 1995; 219:571-8.
78. Moura-da-Silva AM, Butera D, Tanjoni I. Importance of snake venom metallopro-teinases in cell biology: effects on platelets, inflammatory and endothelial cells. Current Pharmaceutical Design 2007; 13:2893-905. (Pubitemid 351545892)
79. Neto EH, Coelho AL, Sampaio A.L., Henriques MD, Marcinkiewicz C, de Freitas MS, et al Activation of human T lymphocytes via integrin signaling induced by RGD-disintegrins. Biochimicaet Biophysica Acta 2007; 1773:176-84. (Pubitemid 46151693)
80. Okuda D, Morita T. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus pis-civorus: the unique effect of piscivostatin on platelet aggregation. Journal of Biochemistry 2001; 130:407-15. (Pubitemid 32845695)
81. Okuda D, Koike H, Morita T. A new gene structure of the disintegrin family: a subunit of dimeric disintegrin has a short coding region. Biochemistry 2002; 41:14248-54. (Pubitemid 35403344)
82. Oliva IB, Coelho RM, Barcellos G.G., Saldanha-Gama R, Wermelinger LS, Marcinkiewicz C, et al Effect of RGD-disintegrins on melanoma cell growth and metastasis: involvement of the actin cytoskeleton, FAK and c-Fos. Toxicon 2007; 50:1053-63. (Pubitemid 350087173)
83. Oshikawa K, Terada S. Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom. Journal of Biochemistry 1999; 125:31-5. (Pubitemid 29085958)
84. Olfa KZ, Luis J, Daoud S., Bazaa A, Srairi Abid N, Andreotti N, et al Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis. Laboratory Investigation 2005; 85:1507-16.
85. Pechkovsky DV, Scaffidi AK, Hackett T.L., Ballard J., Shaheen F, Thompson PJ, et al Transforming growth factor beta1 induces alphavbeta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway. Journal of Biological Chemistry 2008; 283:12898-908.
86. Pilorget A, Conesa M, Sarray S, Michaud-Levesque J, Daoud S, Kim KS, et al. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo. Journal of Cell Physiology 2007; 211:307-15. (Pubitemid 46580084)
87. Pyrko P, Wang W, Markland F.S., Swenson SD, Schmitmeier S, Schönthal AH, et al The roleofcontortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model. Journal of Neurosurgery 2005; 103:526-37. (Pubitemid 43186645)
88. Rahman S, Lu X, Kakkar V.V., Authi KS The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg Gly Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Biochemical Journal 1995; 312:223-32.
89. Ramos OH, Selistre-de-Araujo HS. Snake venom metalloproteases-structure and function of catalytic and disintegrin domains. Comparative Biochemistry and Physiology 2006; 142:328-46.
90. Ramos OH, Terruggi CH, Ribeiro J.U., Cominetti MR, Figueiredo CC, Bérard M, et al Modulation of in vitro and in vivo angiogenesis by alternagin-C, a disintegrin-like protein from Bothrops alternatus snake venom and by a peptide derived from its sequence. Archives of Biochemistry and Biophysics 2007; 461:1-6. (Pubitemid 46627531)
91. Reynolds AR, Hart IR, Watson A.R., Welti JC, Silva RG, Robinson SD, et al Stimulation of tumorgrowth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nature Medicine 2009; 15:392-400.
92. Rosenow F, Ossig R, Thormeyer D, Gasmann P, Schlüter K, Brunner G, et al. Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis. Neoplasia 2008; 10:168-76 [corrected].
93. Saegusa J, Akakura N, Wu C.Y., Hoogland C., Ma Z, Lam KS, et al Proinflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. Journal of Biological Chemistry 2008; 283:26107-15.
94. Saldanha-Gama R., Moraes JA, Mariano-Oliveira A, Coelho A.L., Walsh EM, Marcinkiewicz C, et al alpha(9)beta(1) integrin engagement inhibits neutrophil spontaneous apoptosis: involvement of Bcl-2 family members. Biochimica et Biophysica Acta 2010; 1803:848-57.
95. Sarray S, Srairi N, Hatmi M., Luis J, Louzir H, Regaya I., et al Lebecetin, a potent antiplatelet C-type lectin from Macrovipera lebetina venom. Biochimica et Biophysica Acta 2003; 1651:30-40. (Pubitemid 38234550)
96. Sanchez EE, Rodriguez-Acosta A, Palomar R., Lucena SE, Bashir S, Soto JG, et al Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion. Archives of Toxicology 2009; 83:271-9.
97. Sanz L, Chen RQ, Perez A, Hilario R., Juarez P, Marcinkiewicz C, et al cDNA cloning and functional expression of jerdostatin, a novel RTS-disintegrin from Trimeresu-rusjerdonii and a specific antagonist of the α1β1 integrin. Journal of Biological Chemistry 2005; 208:40714-22. (Pubitemid 41780562)
98. Scarborough RM, Naughton MA, Teng W, Rose J.W., Phillips DR, Nannizzi L, et al Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. Journal of Biological Chemistry 1993; 268:1066-73. (Pubitemid 23019743)
99. Schmitmeier S, Markland FS, Ritter M.R., Sawcer DE, Chen TC Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro. Cell Communication and Adhesion 2003; 10:1-16. (Pubitemid 36986818)
100. Schmitmeier S, Markland FS, Schönthal AH, Chen TC Potent mimicry of fibronectin-induced intracellular signaling in glioma cells by the homodimeric snake venom disintegrin contortrostatin. Neurosurgery 2005; 57:141-53. (Pubitemid 40944179)
101. Schwartz MA, McRoberts K, Coyner M., Andarawewa KL, Frierson HFJr, Sanders JM, et al Integrin agonists as adjuvants in chemotherapy for melanoma. Clinical Cancer Research 2008; 14:6193-7.
102. Sekimoto H, Eipper-Mains J, Pond-Tor S, Boney CM (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells. Molecular Endocrinology 2005; 19:1859-67. (Pubitemid 41007897)
103. Shah PP, Fong MY, Kakar SS PTTG induces EMT through integrin aVβ3-focal adhesion kinase signaling in lung cancer cells. Oncogene 2012; 31:3124-35.
104. Sheu JR, Lin CH, Peng H.C., Huang TF Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proceedings of the Society for Experimental Biology and Medicine 1996; 213:71-9.
105. Soszka T, Knudsen KA, Beviglia L, Rossi C., Poggi A, Niewiarowski S. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albo-labrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Experimental Cell Research 1991; 196:6-12. (Pubitemid 121006364)
106. Souza DH, Iemma MR, Ferreira L.L., Faria JP, Oliva ML, Zingali RB, et al The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion. Archives of Biochemistry and Biophysics 2000; 348:341-50. (Pubitemid 32012809)
107. Staiano N, Della Morte R, Di Domenico C, Tafuri S, Squillacioti C., Belisario MA Echistatin inhibits pSykand pp125FAK phosphorylation in fibrinogen-adherent platelets. Biochimie 1997; 79:769-73. (Pubitemid 28073483)
108. Staniszewska I, Zaveri S, Del Valle L, Oliva I, Rothman V.L., Croul SE, et al Interaction of α9β1 integrin with thrombospondin-1 promotes angiogenesis. Circulation Research 2007; 100:1308-16. (Pubitemid 46742921)
109. Staniszewska I, Sariyer IK, Lecht S, Brown M.C., Tuszynski GP, Safak M, et al The integrin α9β1 is a receptor for nerve growth factor and other neurotrophins. Journal of Cell Science 2008; 121:504-13. (Pubitemid 351405059)
110. Staniszewska I, Walsh EM, Rothman V.L., Gaathon A., Tuszynski GP, Calvete JJ, et al Effect of VP12 and viperistatin on inhibition of collagen-receptor- dependent melanoma metastasis. Cancer Biology and Therapy 2009; 8:1507-16.
111. Surazynski A, Sienkiewicz P, Wolczynski S., Palka J. Differential effects of echistatin and thrombin on collagen production and prolidase activity in human dermal fibroblasts and their possible implication inbeta1-integrin- mediated signaling. Pharmacological Research 2005; 51:217-21. (Pubitemid 40127213)
112. Swenson S, Ramu S, Markland FS Jr. Anti-angiogenesis and RGD-containing snake venom disintegrins. Current Pharmaceutical Design 2007; 13:2860-71. (Pubitemid 351545889)
113. Tian J, Paquette-Straub C, Sage E.H., Funk SE, Patel V, Galileo D, et al Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin. Toxicon 2007; 49:899-908. (Pubitemid 46678124)
114. Trummal K, Tonismagi K, Paalme V, Jarvekulg L, Siigur J, Siigur E. Moleculardiversity of snake venom nerve growth factors. Toxicon 2011; 58:363-8.
115. Tseng YL, Peng HC, Huang TF Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production. Journal of Biomedical Science 2004; 11:683-91.
116. Vija H, Samel M, Siigur E., Aaspõllu A, Tonismagi K., Trummal K, et al VGD and MLD-motifs containing heterodimeric disintegrin viplebedin-2 from Vipera lebetina snake venom. Purification and cDNA cloning. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2009; 153:572-80.
117. Vlahakis NE, Young BA, Atakilit A, Hawkridge A.E., Issaka RB, Boudreau N, et al Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. Journal of Biological Chemistry 2007; 282:15187-96. (Pubitemid 47093385)
118. Walsh EM, Marcinkiewicz C. Non-RGD-containing snake venom disintegrins, functional and structural relations. Toxicon 2011; 58:355-62.
119. Walsh EM, Kim R, Del Valle L, Weaver M, Sheffield J., Lazarovici P, et al Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis. Neuro-Oncology 2012; 14:890-901.
120. Wang R, Kini RM, Chung MC Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (Malayan pit viper): synergistic and noncovalent interaction between its subunits. Biochemistry 1999; 38: 7584-93.
121. Wang YJ, Gualco E, Peruzzi F, Sawaya B, Passiatore G, Marcinkiewicz C, et al. Interaction between serine phosphorylated IRS-1 and β1-integrin affects the stability of neuronal processes. Journal of Neuroscience Research 2007; 85:2360-73. (Pubitemid 47204751)
122. Wu WB, Peng HC, Huang TF Disintegrin causes proteolysis of beta-catenin and apo-ptosis of endothelial cells. Involvement of cell-cell and cell-ECM interactions in regulating cell viability. Experimental Cell Research 2003; 286:115-27.
123. Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Molecular Diversity 2006; 10:515-27. (Pubitemid 44885229)
124. Yang RS, Tang CH, Chuang W.J., Huang TH, Peng HC, Huang TF, et al Inhibition of tumor formation by snake venom disintegrin. Toxicon 2005; 45:661-9.
125. Ye F, Kim C, Ginsberg MH Molecular mechanism of inside-out integrin regulation. Journal of Thrombosis and Haemostasis 2011; 9:20-5.
126. Yeh CH, Peng HC, Huang TF Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood 1998; 92:3268-76. (Pubitemid 28492334)
127. Zhou Q, Sherwin RP, Parrish C, Richters V., Groshen SG, Tsao-Wei D, et al Contortro-statin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression. Breast Cancer Research and Treatment 2000; 61:249-60. (Pubitemid 30609558)
128. Zhou XD, Jin Y, Chen R.Q., Lu QM, Wu JB, Wang WY, et al Purification, cloning and biological characterization of a novel disintegrin from Trimeresurus jerdonii venom. Toxicon 2004; 43:69-75. (Pubitemid 38230876)